Effect of a monoamine oxidase inhibitor (mebanazine) on brain glucose-6-phosphate dehydrogenase activity.
D000818:Animals; D001555:Benzene Derivatives / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D003864:Depression, Chemical; D005954:Glucosephosphate Dehydrogenase / Q000096:biosynthesis / Q000378:metabolism*; D006834:Hydrazines / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009928:Organ Specificity; D010902:Pituitary Gland / Q000187:drug effects / Q000201:enzymology*; D051381:Rats
D001555:Benzene Derivatives; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D005954:Glucosephosphate Dehydrogenase